Non-PVC IV Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Non-PVC IV Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Non-PVC IV Bags Market is expected is anticipated to grow with a CAGR of 5.5% during the forecast period (2022 - 2027).

The COVID-19 pandemic had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of treatment services. As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the COVID-19 pandemic, there was a 46% decrease in the diagnoses of the six most common cancer types - breast, colorectal, lung, pancreatic, gastric, and esophageal cancers. Thus, the decreasing diagnosis and treatment have impacted the demand for non-PVC IV bags.

The factors that are attributed to the market growth are the increasing natality rate, the environment-friendly nature of non-PVC IV bags, and increasing government initiatives.

In addition, there is an increasing demand for non-PVC IV bags in the treatment of oncology, mainly for chemotherapy and targeted drug delivery as most of the therapeutic agents are susceptible to interactions with plasticizers and have a propensity to transform into harmful agents.

Non-PVC IV bags helps in minimizing the risk associated with conventional IV bags such as difficulty in transportation, and the interaction of drugs with the packaging material and disposable containers. Thus, the advantages offered by the PVC-free IV bags increase the demand for using non-PVC Iv bags thus shifting the company’s focus on manufacturing PVC-free bags which is expected to increase the market growth. For instance,

The rising prevalence of cancer among the population is expected to increase the market growth over the forecast period. For instance, according to the January 2022 update by Breastcancer.org, about 1 in 8 United States women (about 13%) will develop invasive breast cancer throughout their lifetime. In addition, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States as compared to an estimated 276,480 new breast cancer cases occurred in 2020. Additionally, as per GLOBOCAN 2020 fact sheet,18.3% of new cases of cancers were reported in India in 2020, out of which cervical cancer accounted for 9.4% of all cancers. As per the same source, 300 114 new cancer cases in males were reported in Brazil in 2020, out of which 97 278 cases were of prostate cancer. In addition, 292 098 new cancer cases in females were reported in Brazil, in 2020. This is expected to increase the demand for PVC-free IV bags as cancer treatment deprives the human body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, which increases the demand for delivering parenteral nutrition to the patients, thereby propelling the market growth. Thus, the aforementioned factors are expected to increase market growth over the forecast period.

In addition, the growing burden of chronic diseases such as cardiovascular diseases, respiratory diseases and others are expected to increase the market growth. For instance, as per the article titled “Evolution of Heart Surgery” published in June 2021, in the United States, heart disease is the top cause of death for both men and women. In 2020, about 500,000 open heart surgeries are carried out in the year. Therefore, the increasing requirement for cardiac surgeries ultimately increases the demand for non-PVC IV bags for transporting fluids, thereby propelling the market growth. Also, according to World Health Organization (WHO), 2022 updates, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and nearly 90% of COPD deaths occur among people under 70 years of age in low- and middle-income countries (LMIC). This is expected to increase the demand for administering intravenous fluids after cardiac surgery and for patients treated for acute exacerbations which is anticipated to increase the demand for non-PVC IV bags, thereby boosting the market growth.

However, the high cost of non-PVC IV bags is likely to hinder the market growth over the forecast period.

Key Market TrendsBy Material, Ethylene Vinyl Acetate (EVA) in Non-PVC IV Bags Market is Estimated to Witness a Healthy Growth in Future.

Ethylene Vinyl Acetate (EVA) is estimated to witness significant growth in the non-PV IV bags market over the forecast period owing to the factors such as the increasing usage of non-PVC IV bags in blood banks and the storage of frozen mixture, growing awareness and increasing demand for blood and blood component storage due to the rising number of blood banks around the globe may boost segment growth.

In addition, a high prevalence of chronic kidney diseases and the need for parenteral nutrition therapy is also expected to increase the demand for non-PVC IV bags. For instance, according to the 2022 statistics published by the Centers for Disease Control and Prevention, 37 million people in the United States were estimated to have chronic kidney disease in 2020. As per the same source, about 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease. Additionally, as per the National Institute of Diabetes and Digestive and Kidney Diseases, about 786,000 people in the United States were living with end-stage renal diseases, with 71% on dialysis and 29% with a kidney transplant. Thus, the increasing burden of chronic kidney disease among the population is expected to increase the demand for dialysis which in turn is anticipated to increase the demand for non-PVC IV bags for administering drugs and nutrition, thereby fueling the market growth.

Hence, owing to the above-mentioned factors, the studied segment market is expected to grow over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same During the Forecast Period

North America is expected to hold a significant market share in the Non-PVC IV Bags market due to rising healthcare spending, increasing stringency of regulatory bodies towards patient care and safety, and growing research and development expenditure.

The rising prevalence of diseases like cancers and established healthcare infrastructure are also contributing to the growth of the market. For instance, according to the American Cancer Society, in 2022, an estimated 268,490 new prostate cancer cases was identified, and 34,500 deaths were reported in the United States. Also, according to the statistics published by the American Society of Clinical Oncology, in May 2022, an estimated 151,030 adults in the United States will be diagnosed with colorectal cancer, in 2022. In addition, an estimated 1,880,725 people were diagnosed with colorectal cancer in 2020. Similarly, according to the January 2022 update by Breastcancer.org, about 1 in 8 United States women (about 13%) are expected to develop invasive breast cancer throughout their lifetime. In addition, as per the same source, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States as compared to an estimated 276,480 new breast cancer cases occurred in 2020. Thus, the increasing burden of cancer among the population is anticipated to increase the demand for non-PVC IV bags for drug delivery during chemotherapy and targeted treatment of cancer patients, thereby fueling market growth.

In addition, the rising healthcare spending in the region is expected to increase the company’s activities for developing non-PVC IV bags as well as switching to PVC-free manufacturing of IV bags, which is expected to propel the market growth over the forecast period. For instance, according to the Organization for Economic Co-operation and Development (OECD), in June 2022, United States healthcare spending, in 2021 was 17.8% of the total GDP of the country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled “CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures”, it has been observed that the annual growth in national health spending is expected to average 5.1% over 2021-2030. In addition, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030.

Furthermore, increasing adoption of novel drug delivery systems and technological advancements are also expected to fuel the Non-PVC IV Bags Market in this region. For instance, in September 2021, B. Braun Medical Inc launched a new CARESAFE IV Administration Sets with Optional AirStop component, a portfolio of IV administration sets, that are not made with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP), in the United States.

Hence, owing to the above-mentioned factors, the non-PVC IV bags market is expected to grow in the region over the forecast period.

Competitive Landscape

The Non-PVC IV Bags Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are B. Braun Medical Inc., Baxter, JW Life Science, RENOLIT SE, Fresenius Kabi, Shanghai Xin Gen Eco-Technologies Co., Ltd, Polycine GmbH, KRATON CORPORATION, and Angiplast Pvt. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.